{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:32:35Z","timestamp":1789903955998,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ajog.2012.07.008","type":"journal-article","created":{"date-parts":[[2012,7,15]],"date-time":"2012-07-15T23:17:17Z","timestamp":1342394237000},"page":"405.e1-405.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["Use of topiramate in pregnancy and risk of oral clefts"],"prefix":"10.1016","volume":"207","author":[{"given":"Andrea V.","family":"Margulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Gilboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Werler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray A.","family":"Mittleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hernandez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2012.07.008_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ajog.2012.07.008_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1471-0528.2009.02141.x","article-title":"The management of epilepsy in pregnancy","volume":"116","author":"Walker","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2012.07.008_bib3","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2012.07.008_bib4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/aje\/153.10.961","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy","volume":"153","author":"Hernandez-Diaz","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2012.07.008_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","article-title":"Use of antiepileptic medications in pregnancy in relation to risks of birth defects","volume":"21","author":"Werler","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajog.2012.07.008_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0404.2009.01260.x","article-title":"Changing patterns of antiepileptic drug use in pregnant Australian women","volume":"121","author":"Vajda","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ajog.2012.07.008_bib7","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2011.624","article-title":"Newer-generation antiepileptic drugs and the risk of major birth defects","volume":"305","author":"Molgaard-Nielsen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2012.07.008_bib8","first-page":"S47","article-title":"Topiramate use in women of childbearing age from the U.S. National Health and Human Nutrition Examination Survey (NHANES) (abstract)","volume":"20","author":"Dugan","year":"2011","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.ajog.2012.07.008_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1526-4610.2010.01650.x","article-title":"Commentary: triptan use during pregnancy: a safe choice?","volume":"50","author":"Kurth","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.ajog.2012.07.008_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ncl.2010.03.025","article-title":"Treatment options for parasomnias","volume":"28","author":"Attarian","year":"2010","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ajog.2012.07.008_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5664\/jcsm.27883","article-title":"Best practice guide for the treatment of nightmare disorder in adults","volume":"6","author":"Aurora","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.ajog.2012.07.008_bib12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1345\/aph.1H178","article-title":"Topiramate for binge-eating disorder associated with obesity","volume":"40","author":"Tata","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajog.2012.07.008_bib13","article-title":"Pharmacological interventions for borderline personality disorder","volume":"6","author":"Stoffers","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2012.07.008_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4088\/JCP.09m05266gre","article-title":"Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder","volume":"72","author":"Berlin","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ajog.2012.07.008_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1479-828X.2007.00781.x","article-title":"The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies","volume":"47","author":"Vajda","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2012.07.008_bib17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.reprotox.2008.03.001","article-title":"The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies","volume":"25","author":"Ornoy","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2012.07.008_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","article-title":"Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register","volume":"71","author":"Hunt","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ajog.2012.07.008_bib19","first-page":"408","article-title":"Comparative safety of topiramate during pregnancy","author":"Hernandez-Diaz","year":"2010","journal-title":"Birth Defects Research (Part A)"},{"key":"10.1016\/j.ajog.2012.07.008_bib20","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","article-title":"Folic acid antagonists during pregnancy and the risk of birth defects","volume":"343","author":"Hernandez-Diaz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2012.07.008_bib21","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2012.07.008_bib22","doi-asserted-by":"crossref","first-page":"51.e1","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2012.07.008_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/phr\/116.S1.32","article-title":"The National Birth Defects Prevention Study","volume":"116","author":"Yoon","year":"2001","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ajog.2012.07.008_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the National Birth Defects Prevention Study","volume":"67","author":"Rasmussen","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2012.07.008_bib25","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60695-4","article-title":"Cleft lip and palate","volume":"374","author":"Mossey","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2012.07.008_bib26","author":"McNamara"},{"key":"10.1016\/j.ajog.2012.07.008_bib27","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1212\/01.wnl.0000349659.03687.a7","article-title":"Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register (letter to the editor)","volume":"72","author":"Martinez-Frias","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ajog.2012.07.008_bib29","first-page":"356","article-title":"Assessment of the teratogenic risk in fetuses exposed to topiramate in utero","volume":"91","author":"Day","year":"2011","journal-title":"Birth Defects Res (Part A)"},{"key":"10.1016\/j.ajog.2012.07.008_bib30","first-page":"262","article-title":"Retrospective analysis of major congenital malformations (MCMs) and oral clefts (OC) associated with in utero topiramate exposure","volume":"52","author":"Pack","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ajog.2012.07.008_bib31","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2012.07.008_bib32","doi-asserted-by":"crossref","first-page":"c6581","DOI":"10.1136\/bmj.c6581","article-title":"Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study","volume":"341","author":"Jentink","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2012.07.008_bib33","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","article-title":"Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy","volume":"70","author":"Holmes","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ajog.2012.07.008_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajog.2012.07.008_bib35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ajog.2012.07.008_bib36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1474-4422(05)70224-6","article-title":"Birth defects after prenatal exposure to antiepileptic drugs","volume":"4","author":"Perucca","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ajog.2012.07.008_bib37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1528-1167.2007.01021.x","article-title":"Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study","volume":"48","author":"Cunnington","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ajog.2012.07.008_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-200427030-00004","article-title":"Malformation rates in children of women with untreated epilepsy: a meta-analysis","volume":"27","author":"Fried","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajog.2012.07.008_bib40","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/bdra.20735","article-title":"Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006","volume":"88","author":"Parker","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2012.07.008_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1597\/09-217","article-title":"Prevalence at birth of cleft lip with or without cleft palate: data from the International Perinatal Database of Typical Oral Clefts (IPDTOC)","volume":"48","year":"2011","journal-title":"Cleft Palate Craniofac J"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812007454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812007454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:46:29Z","timestamp":1757587589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937812007454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0002937812007454"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2012.07.008","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of topiramate in pregnancy and risk of oral clefts","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2012.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}